Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival-Reference-Cited by-同舟云学术

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

Published:2004-01 Issue:1 Volume:32 Page:28-35
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Khouri Issa F,Lee Ming-Sheng,Saliba Rima M,Andersson Borje,Anderlini Paolo,Couriel Daniel,Hosing Chitra,Giralt Sergio,Korbling Martin,McMannis John,Keating Michael J,Champlin Richard E

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference27 articles.

1. Chronic lymphocytic leukemia;Keating;Semin Oncol,1999

2. Combination chemo-antibody therapy with fludarabine, cyclophosphamide, and rituximab achieves high CR rate in previously untreated chronic lymphocytic leukemia;Keating;Blood,2000

3. Therapeutic role of alemtuzumab (Campath-IH) in patients who have failed fludarabine: results of a large international study;Keating;Blood,2000

4. Allogeneic blood or marrow transplantation for chronic lymphocytic leukemia: timing of transplantation and potential effect of fludarabine on acute graft-vs-host disease;Khouri;Br J Haematol,1997

5. Long term follow-up of patients with chronic lymphocytic leukemia treated with allogeneic hematopoietic transplantation;Khouri;Cytotherapy,2002

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience;Bone Marrow Transplantation;2019-09-03

2. Reduced intensity is preferred over myeloablative conditioning allogeneic HCT in chronic lymphocytic leukemia whenever indicated: A systematic review/meta-analysis;Hematology/Oncology and Stem Cell Therapy;2018-06

3. New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?;Expert Opinion on Biological Therapy;2017-05-22

4. Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study;Bone Marrow Transplantation;2016-02-15

5. Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia;Thomas’ Hematopoietic Cell Transplantation;2016-01-01